CytomX Therapeutics CTMX Balance Sheet (2014-2026)

NASDAQ CTMX
$3.61 -0.08 (-2.04%)
As of: Sep 4, 2026 · 12:49 PM EDT
Reported Financials

CytomX Therapeutics Quarterly Balance Sheet

Periods 48 quarters
Latest Jun 2026

CytomX Therapeutics reported total assets of $381.23M and total liabilities of $79.16M for the quarter ended Jun 2026, up 117.8% year over year. This balance sheet covers 48 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
236.28M205.53M163.49M129.29M95.03M193.65M56.36M57.54M26.02M17.17M36.19M43.25M40.58M38.05M47.60M49.04M34.19M12.67M28.83M17.22M
Short-term InvestmentsInvestments (Current)
0.01M99.70M99.04M98.88M99.25M148.15M123.32M168.09M157.34M114.10M93.94M77.01M62.57M32.28M109.05M109.44M124.39M317.88M313.06M
Cash & Current Investments
236.29M305.23M262.53M228.16M194.29M193.65M204.50M180.86M194.11M174.51M150.28M137.18M117.59M100.62M79.89M158.09M143.63M137.05M346.71M330.28M
Receivables - NetNet Receivables
0.90M0.79M1.02M1.01M1.71M35.99M1.09M1.90M2.42M3.43M13.18M2.77M3.35M3.10M1.96M1.87M1.63M2.01M0.65M37.50M
Receivables - OtherOther Receivables
0.02M0.50M1.50M1.50M
Receivables
0.90M0.79M1.02M1.01M1.71M35.99M1.09M1.90M2.42M3.43M13.18M2.77M3.35M3.12M1.96M1.87M1.63M2.51M2.15M39.00M
Prepaid Assets
3.82M4.29M4.90M3.59M4.28M7.47M6.68M5.04M4.67M5.00M3.79M3.12M3.24M3.58M4.79M4.67M3.96M4.86M5.74M4.46M
Current Assets
241.00M310.30M268.44M232.77M200.28M237.10M212.28M187.80M201.20M182.94M167.25M143.08M124.18M107.31M86.63M164.62M149.22M143.92M353.10M373.15M
Non-Current Assets
Construction in Progress
0.31M0.70M0.37M
Property, Plant & Equipment (Net)PP&E (Net)
6.27M5.96M6.09M5.92M5.71M5.07M4.57M4.50M4.06M3.96M3.57M3.32M2.94M2.47M2.23M1.95M1.72M1.30M1.09M1.08M
Long-Term Investments
99.97M
Goodwill
0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M
Intangibles
1.06M1.02M0.98M0.95M0.91M0.88M0.84M0.80M0.77M0.73M0.69M0.66M0.62M0.58M0.55M0.51M0.47M0.44M0.40M0.36M
Goodwill & Intangibles
2.01M1.97M1.93M1.90M1.86M1.82M1.79M1.75M1.72M1.68M1.64M1.60M1.57M1.53M1.50M1.46M1.42M1.39M1.35M1.31M
Long-Term Deferred Tax
Other Non-Current Assets
0.92M0.92M0.92M0.92M0.92M0.92M0.92M0.92M0.92M0.92M0.92M0.92M1.03M1.03M1.03M1.03M1.03M1.53M1.53M0.61M
Non-Current Assets
130.24M29.11M28.38M27.32M26.21M23.79M22.35M21.38M19.96M18.86M17.44M16.14M14.80M13.23M11.87M10.44M9.04M7.64M6.26M8.07M
Assets
371.23M339.41M296.82M260.09M226.49M260.89M234.63M209.19M221.17M201.79M184.69M159.22M138.98M120.53M98.50M175.06M158.25M151.57M359.36M381.23M
Liabilities
Current Liabilities
Accounts Payables
1.52M2.82M1.72M1.92M5.18M2.81M2.20M1.03M1.71M1.46M1.96M0.61M1.42M1.09M0.28M0.23M0.65M1.30M1.37M1.94M
Payables
1.52M2.82M1.72M1.92M5.18M2.81M2.20M1.03M1.71M1.46M1.96M0.61M1.42M1.09M0.28M0.23M0.65M1.30M1.37M1.94M
Accumulated Expenses
25.17M34.24M31.03M31.73M31.34M24.45M22.27M20.07M20.69M17.60M14.22M13.62M16.74M12.34M11.41M11.50M12.41M14.20M11.92M12.35M
Other Accumulated Expenses
0.55M0.71M0.94M0.14M0.18M0.26M0.36M0.16M0.34M0.31M0.46M0.20M0.29M0.49M0.06M0.11M0.34M0.14M1.13M0.35M
Short term Debt
Current Leases
3.62M3.73M3.85M3.96M4.08M4.20M4.33M4.46M4.59M4.72M4.86M5.00M5.14M5.29M5.44M5.60M4.24M2.86M1.50M
Current Taxes
Current Deferred Revenue
40.84M284.76M276.73M264.89M255.46M301.33M283.92M261.15M236.66M212.31M183.37M160.48M129.62M94.06M49.44M32.29M27.92M28.47M18.90M54.70M
Total Current Liabilities
67.53M77.87M87.40M94.64M123.64M152.61M151.26M141.38M146.79M155.91M144.54M142.86M119.23M85.77M50.20M39.22M41.03M46.62M34.02M39.86M
Non-Current Liabilities
Non-Current Debt
Non-Current Deffered Revenue
254.26M243.94M222.09M203.91M168.33M180.06M157.13M140.87M112.26M80.05M59.74M36.71M33.56M26.86M16.21M10.24M5.54M1.59M0.98M30.62M
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Operating Leases
19.02M18.06M17.08M16.08M15.05M13.97M12.87M11.75M10.60M9.38M8.15M6.88M5.60M4.24M2.86M1.44M4.21M
Other Non-Current Liabilities
0.22M2.76M3.89M3.94M3.99M4.05M4.12M4.18M4.24M4.30M4.35M4.41M4.47M
Total Non-Current Liabilities
314.62M346.64M294.00M269.65M245.35M212.43M186.45M158.38M116.87M69.27M50.91M46.57M48.20M35.00M74.69M
Total Liabilities
340.80M339.87M326.56M314.62M307.03M346.64M321.27M294.21M272.40M249.24M216.37M190.45M162.43M120.99M73.45M55.15M50.87M52.56M39.41M79.16M
Shareholder's Equity
Total Debt
Common Equity
30.43M-0.46M-29.74M-54.54M-80.54M-85.75M-86.64M-85.03M-51.24M-47.45M-31.68M-31.23M-23.45M-0.46M25.05M119.91M107.39M99.01M319.94M302.07M
Liabilities and Shareholders Equity
371.23M339.41M296.82M260.09M226.49M260.89M234.63M209.19M221.17M201.79M184.69M159.22M138.98M120.53M98.50M175.06M158.25M151.57M359.36M381.23M
Retained Earnings
-588.74M-623.56M-655.54M-685.04M-714.10M-722.88M-726.19M-727.28M-724.28M-723.45M-709.66M-716.19M-710.46M-691.58M693.10M788.08M789.72M810.84M1,050.04M1,053.12M
Preferred Shares
Treasury Shares